These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38982785)

  • 1. Bladder Cancer Patients with Elevated SPRR1B Expression Experiencing a Poor Prognosis.
    Cheng H; Wang R; Lu L; Gong Y; Li L; Wang Z
    Arch Esp Urol; 2024 Jun; 77(5):554-569. PubMed ID: 38982785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of small proline-rich protein 1B (SPRR1B) as a prognostically predictive biomarker for lung adenocarcinoma by integrative bioinformatic analysis.
    Zhang Z; Shi R; Xu S; Li Y; Zhang H; Liu M; Zhu G; Chen C; Pan Z; Liu H; Chen J
    Thorac Cancer; 2021 Mar; 12(6):796-806. PubMed ID: 33501784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small proline-rich protein-1B is overexpressed in human oral squamous cell cancer stem-like cells and is related to their growth through activation of MAP kinase signal.
    Michifuri Y; Hirohashi Y; Torigoe T; Miyazaki A; Fujino J; Tamura Y; Tsukahara T; Kanaseki T; Kobayashi J; Sasaki T; Takahashi A; Nakamori K; Yamaguchi A; Hiratsuka H; Sato N
    Biochem Biophys Res Commun; 2013 Sep; 439(1):96-102. PubMed ID: 23954638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of ABCC3 promotes cell proliferation, drug resistance, and aerobic glycolysis and is associated with poor prognosis in urinary bladder cancer patients.
    Liu X; Yao D; Liu C; Cao Y; Yang Q; Sun Z; Liu D
    Tumour Biol; 2016 Jun; 37(6):8367-74. PubMed ID: 26733163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DGUOK-AS1 promotes cervical squamous cell carcinoma progression by suppressing miR-499a-5p that targets SPRR1B in vitro.
    Song Y; Pan H; Yang L; Fan Y; Zhang H; Pan M; Zhang Y
    Biochem Biophys Res Commun; 2021 Dec; 585():177-184. PubMed ID: 34808501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and RNA expression integrated signature for urothelial bladder cancer prognosis.
    Xiong J; Xiong K; Bing Z
    Cancer Biomark; 2018 Feb; 21(3):535-546. PubMed ID: 29226853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of kinesin family member 4A inhibits cell proliferation, migration, and invasion while promoting apoptosis of urothelial bladder carcinoma cells.
    Zhang C; Wang M; Ying Y; Meng F; Gao H; Zeng S; Zhu Y; Liu A; Zhang Z; Xu C
    Cancer Med; 2023 Jun; 12(11):12581-12592. PubMed ID: 37039264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of oral squamous cell carcinoma markers MUC2 and SPRR1B downstream of TANGO.
    Sasahira T; Kurihara-Shimomura M; Shimomura H; Bosserhoff AK; Kirita T
    J Cancer Res Clin Oncol; 2021 Jun; 147(6):1659-1672. PubMed ID: 33620575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rac3 Expression and its Clinicopathological Significance in Patients With Bladder Cancer.
    Chen M; Nie Z; Cao H; Gao Y; Wen X; Zhang C; Zhang S
    Pathol Oncol Res; 2021; 27():598460. PubMed ID: 34257551
    [No Abstract]   [Full Text] [Related]  

  • 10. Prognostic value of miR-26a and HMGA1 in urothelial bladder cancer.
    Lin R; Shen W; Zhi Y; Zhou Z
    Biomed Pharmacother; 2014 Oct; 68(8):929-34. PubMed ID: 25455159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased expression of microRNA-31 associates with aggressive tumor progression and poor prognosis in patients with bladder cancer.
    Wang S; Li Q; Wang K; Dai Y; Yang J; Xue S; Han F; Zhang Q; Liu J; Wu W
    Clin Transl Oncol; 2013 Oct; 15(10):849-54. PubMed ID: 23408039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. UCA1 overexpression is associated with less aggressive subtypes of bladder cancer.
    Lebrun L; Milowich D; Le Mercier M; Allard J; Van Eycke YR; Roumeguere T; Decaestecker C; Salmon I; Rorive S
    Oncol Rep; 2018 Nov; 40(5):2497-2506. PubMed ID: 30226613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of HMGB3 protein promotes cell proliferation, migration and is associated with poor prognosis in urinary bladder cancer patients.
    Li M; Cai Y; Zhao H; Xu Z; Sun Q; Luo M; Gu L; Meng M; Han X; Sun H
    Tumour Biol; 2015 Jun; 36(6):4785-92. PubMed ID: 25647262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanism of proinflammatory cytokine-mediated squamous metaplasia in human corneal epithelial cells.
    Li S; Gallup M; Chen YT; McNamara NA
    Invest Ophthalmol Vis Sci; 2010 May; 51(5):2466-75. PubMed ID: 20042643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of repression of squamous differentiation marker, SPRR1B, in malignant bronchial epithelial cells: role of critical TRE-sites and its transacting factors.
    Patterson T; Vuong H; Liaw YS; Wu R; Kalvakolanu DV; Reddy SP
    Oncogene; 2001 Feb; 20(5):634-44. PubMed ID: 11313996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MTHFD2 is a potential oncogene for its strong association with poor prognosis and high level of immune infiltrates in urothelial carcinomas of bladder.
    Zhu L; Liu X; Zhang W; Hu H; Wang Q; Xu K
    BMC Cancer; 2022 May; 22(1):556. PubMed ID: 35581573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Analysis of PTPN6 for Bladder Cancer: An Exploratory Study Based on TCGA.
    Shen C; Liu J; Wang J; Yang X; Niu H; Wang Y
    Dis Markers; 2020; 2020():4312629. PubMed ID: 32454905
    [No Abstract]   [Full Text] [Related]  

  • 18. Small proline-rich protein 1B (SPRR1B) is a biomarker for squamous metaplasia in dry eye disease.
    Li S; Nikulina K; DeVoss J; Wu AJ; Strauss EC; Anderson MS; McNamara NA
    Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):34-41. PubMed ID: 18172072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P3H4 is correlated with clinicopathological features and prognosis in bladder cancer.
    Li W; Ye L; Chen Y; Chen P
    World J Surg Oncol; 2018 Oct; 16(1):206. PubMed ID: 30322400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High CDKN2A/p16 and Low FGFR3 Expression Predict Progressive Potential of Stage pT1 Urothelial Bladder Carcinoma.
    Breyer J; Wirtz RM; Erben P; Worst TS; Stoehr R; Eckstein M; Bertz S; Sikic D; Denzinger S; Burger M; Hartmann A; Otto W;
    Clin Genitourin Cancer; 2018 Aug; 16(4):248-256.e2. PubMed ID: 29525349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.